Evidence map›Paper›PMID 33627011›Full record

ArticleTherapeutic advances in cardiovascular disease

Trace elements in patients with aortic valve sclerosis.

Hataw Al-Taesh, Abuzer Çelekli, Murat Sucu, Seyithan Taysi

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in cardiovascular disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Role of Selenium in Pathologies: An Updated Review.Antioxidants (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hataw Al-TaeshDepartment of Biochemistry Science and Technology, Institute of Natural and Applied Sciences, Faculty of Arts and Science, Gaziantep University, Gaziantep, Turkey.
Abuzer ÇelekliDepartment of Biology, Faculty of Arts and Science, Gaziantep University, Gaziantep, Turkey.
Murat SucuDepartment of Cardiology, Gaziantep University, Gaziantep, 27310, Turkey.ORCID https://orcid.org/0000-0002-3695-5461
Seyithan TaysiDepartment of Medical Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
Gaziantep University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAortic valve sclerosis (AVSc) is defined as the thickening and calcification of aortic valve cusps, in the absence of obstruction of ventricular outflow. AVSc is linked with a clear imbalance in some trace elements.

aimsThe objective of this study was to investigate the relationship between AVSc and serum levels of iron (Fe), zinc (Zn), selenium (Se), and copper (Cu). Additionally, this research aimed to explore the clinical significance of human serum zinc, selenium, copper, and iron concentrations as a potential new biomarker for AVSc patients and to clarify the pathophysiological role in individuals at risk of developing AVSc. PATIENTS AND

methodsThe study included 40 subjects with AVSc (25% male and 75% female) who were compared with a healthy control group with the same gender ratio. AVSc was based on comprehensive echocardiographic assessments. Blood samples were taken and Zn and Cu concentrations were determined through the use of atomic absorption spectroscopy. Se was measured using an inductively coupled plasma mass spectrometry device and Fe was measured using a Beckman Coulter instrument.

resultsThere was a significant difference in the prevalence of diabetes, blood pressure levels, and body mass index between the patients and the healthy subjects (

conclusionPatients with AVSc had an imbalance in some of the trace elements in their blood. The patient group's valves had higher serum Cu levels and lower serum Se, Zn, and Fe concentrations compared with the healthy group's valves. In the valve patients as compared, AVSc had a high prevalence of obesity, hypertension, and diabetes.

Indexed as

Aortic ValveAdultAgedCase-Control StudiesCopperDiabetes MellitusFemaleHeart Valve DiseasesHumansHypertensionIronMaleMiddle AgedObesityRisk AssessmentRisk FactorsCopperIronSeleniumTrace ElementsZincaortic valve sclerosiscopperironseleniumzinc

Identifiers

PMID33627011
PMCPMC7917827
OpenAlexW3133096342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.